Objective:
To develop a rapid, online monitoring strategy for antibody-drug conjugate (ADC) bioconjugation reactions using hydrophobic interaction chromatography (HIC) coupled with mass spectrometry (MS), emphasizing the significance of real-time monitoring in enhancing ADC manufacturing efficiency.
Key Findings:
- Ammonium tartrate provides stronger retention than ammonium acetate, enabling effective separation of complex hydrophobic species, which is crucial for ADC characterization.
- Real-time monitoring revealed that the bioconjugation reaction was dissolution-rate limited, leading to significant process efficiency improvements, which could transform ADC manufacturing.
- Process time was reduced from approximately 16 hours to 90 minutes by optimizing mixing parameters, showcasing the method's potential for practical application.
Interpretation:
The study demonstrates that advanced analytical methods like real-time HIC-MS can transform ADC manufacturing by providing critical insights into the bioconjugation process, enhancing efficiency and product quality, which is vital for meeting regulatory standards.
Limitations:
- The study does not fully explain the mechanism behind the effectiveness of ammonium tartrate at high concentrations, which may hinder broader acceptance.
- Further validation may be needed for broader application across different ADC formulations, particularly in diverse manufacturing environments.
Conclusion:
The integration of real-time analytics in ADC development can lead to better process control and understanding, ultimately improving manufacturing outcomes and ensuring compliance with regulatory expectations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
James Strachan
Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.